SEC Form 4 · accession 0000899243-17-029151
Coherus Oncology, Inc. · CHRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter K. Watler
Officer — Chief Technical Officer
Period of report
Dec 15, 2017
Accepted (ET)
Dec 19, 2017 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001512762
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value | Dec 15, 2017 | A | 5,900 | $0.00 | A | 5,900 | D |
Table II — derivative securities
No Table II lines on this filing.